Michael Gaito - Global Head of J.P. Morgan's Healthcare Investment Banking Group. 

Over the course of his 25 years with the firm, Mike has advised clients on transactions representing over $100 billion, primarily involving strategic advisory and financing assignments for pharmaceutical and biotechnology companies worldwide. He has advised on some of the largest strategic transactions in the history of the biotechnology industry, including advising Pharmacyclics on its $21 billion sale to AbbVie, and Medivation on its defense and ultimate $14 billion sale to Pfizer.